Publication date: Jun 26, 2026
A genetic variant carried by nearly one in three people worldwide has been linked to an increased risk of severe COVID-19, lung fibrosis and other serious lung diseases, as well as altered responses to treatment, in a new international study from the University of Edinburgh and the University of Sydney1. The research, conducted in the UK and Australia, reveals that this common genetic difference di .. .
| Concepts | Keywords |
|---|---|
| Australia | Covid |
| Cancer | Discovered |
| Kidney | Disease |
| Pathwayresearchers | Diseases |
| Enzyme | |
| Fibrosis | |
| Genetic | |
| Hidden | |
| Identified | |
| Lung | |
| Risk | |
| Severe | |
| Team | |
| Variant | |
| Variants |
Semantics
| Type | Source | Name |
|---|---|---|
| drug | DRUGBANK | Nonoxynol-9 |
| drug | DRUGBANK | Vitamin D |
| disease | MESH | Cancer |
| disease | MESH | genetic disorders |
| disease | MESH | disease susceptibility |
| disease | MESH | heart disease |
| disease | MESH | lung cancer |
| disease | MESH | infections |
| disease | MESH | inflammation |
| disease | MESH | COVID-19 |
| disease | MESH | fibrosis |
| disease | MESH | lung diseases |
Original Article
(Visited 1 times, 1 visits today)